Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Using Cardiovascular Magnetic Resonance Identified Fibrosis to Assess Sudden Cardiac Death Risk in Patients With Non-ischemic Dilated Cardiomyopathy and the Unknown Therapeutic Risk Reduction of Contemporary Heart Failure Medication and Implantable Cardioverter-Defibrillators

NCT07415642 is registered in ClinicalTrials.gov with University Medical Center Groningen as lead sponsor.

NCT NCT07415642
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07415642 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Using Cardiovascular Magnetic Resonance Identified Fibrosis to Assess Sudden Cardiac Death Risk in Patients With Non-ischemic Dilated Cardiomyopathy and the Unknown Therapeutic Risk Reduction of Contemporary Heart Failure Medication and Implantable Cardioverter-Defibrillators
Lead sponsor
University Medical Center Groningen
Phase
Not applicable
Overall status
Not yet recruiting
Start date
March 1, 2026
Completion date
December 31, 2032
Enrollment
720 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

sudden cardiac death